pFA6a-kanMX6-P3nmt1-GFP
(Plasmid
#39289)
-
Depositing Labs
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 39289 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepFA6a
- Backbone size w/o insert (bp) 3500
-
Vector typeYeast genomic targeting
-
Selectable markersGentamicin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namenmt1 promoter
-
SpeciesS. pombe (fission yeast)
-
Insert Size (bp)2900
-
Mutation-1163 to +6 of nmt1 locus
-
Entrez Genenmt1 (a.k.a. SPCC1223.02)
-
Tags
/ Fusion Proteins
- A. gossypii translation elongation factor 1a gene terminator (N terminal on insert)
- KanR reverse orientation (N terminal on insert)
- A. gossypii translation elongation factor 1a gene promoter (N terminal on insert)
- GFP (C terminal on insert)
- TADH1 (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (not destroyed)
- 3′ cloning site PacI (not destroyed)
- 5′ sequencing primer Sp6_primer
- 3′ sequencing primer T7_promoter (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Use GFP reverse primer to verify mutation in nmt1 promoter.
1nt deletion at bp#4109 in nmt1 promoter, also missing "AT" @4271. Does not effect function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFA6a-kanMX6-P3nmt1-GFP was a gift from Jurg Bahler & John Pringle (Addgene plasmid # 39289 ; http://n2t.net/addgene:39289 ; RRID:Addgene_39289) -
For your References section:
Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Bahler J, Wu JQ, Longtine MS, Shah NG, McKenzie A 3rd, Steever AB, Wach A, Philippsen P, Pringle JR. Yeast. 1998 Jul;14(10):943-51. 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y PubMed 9717240